BNP Paribas Financial Markets’s RxSight RXST Stock Holding History

BNP Paribas Financial Markets’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$810K	Sell	168,072 -136,716	-45%	-$825K	﹤0.01%	3462
2026 Q1	$1.88M	Sell	304,788 -670,956	-69%	-$5.57M	﹤0.01%	2703
2025 Q4	$10.2M	Buy	975,744 +71,898	+8%	+$721K	﹤0.01%	1600
2025 Q3	$8.13M	Buy	903,846 +422,782	+88%	+$3.71M	﹤0.01%	1673
2025 Q2	$6.25M	Buy	481,064 +265,989	+124%	+$4M	﹤0.01%	1728
2025 Q1	$5.43M	Buy	215,075 +36,824	+21%	+$1.09M	﹤0.01%	1758
2024 Q4	$6.13M	Buy	+178,251	New	+$8.04M	﹤0.01%	1665
2022 Q4	–	Sell	-6,526	Closed	-$78.3K	–	4513
2022 Q3	$78.3K	Buy	+6,526	New	+$89.6K	﹤0.01%	3859

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $432M AUM 37.48% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BNP Paribas Financial Markets's RXST Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its RxSight (RXST) stake by 45% in Q2 2026, selling an estimated $825K and leaving 168,072 shares worth $810K. The position accounts for ﹤0.01% of the portfolio, ranked #3462.

BNP Paribas Financial Markets first reported a position in RXST in Q3 2022 and has held it in 8 quarters since. The position peaked at $10.2M in Q4 2025. 137 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

BNP Paribas Financial Markets held 168,072 shares of RxSight worth $810K as of Q2 2026.
BNP Paribas Financial Markets sold 136,716 RxSight shares in Q2 2026, an estimated $825K.
RxSight made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3462 holding.
BNP Paribas Financial Markets first reported a position in RxSight in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's RxSight position peaked at $10.2M in Q4 2025.
137 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.